Lisata Therapeutics Inc (LSTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Sales | 49 | 65 | 81 | 107 | 27 |
| Cost of Goods | 34 | 44 | 61 | 71 | 33 |
| Gross Profit | 15 | 21 | 21 | 37 | -6 |
| Operating Expenses | 1,523 | 959 | 1,231 | 1,714 | 2,544 |
| Operating Income | -1,474 | -894 | -1,149 | -1,606 | -2,517 |
| Interest Expense | 274 | 239 | 23 | 6 | 10 |
| Other Income | 0 | 89 | 13 | -179 | 230 |
| Pre-tax Income | -1,748 | -1,044 | -1,160 | -1,792 | -2,296 |
| Income Tax | N/A | N/A | -1,160 | N/A | N/A |
| Net Income Continuous | -1,748 | -1,044 | 0 | -1,792 | -2,296 |
| Net Income Discontinuous | N/A | N/A | N/A | -241 | 269 |
| Net Income | $-1,748 | $-1,044 | $-1,160 | $-2,033 | $-2,027 |
| EPS Basic Total Ops | -8,095.95 | -0.05 | -0.05 | -0.09 | -0.14 |
| EPS Basic Continuous Ops | -8,055.00 | -0.04 | 0.00 | -0.08 | -0.16 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | -0.01 | 0.02 |
| EPS Diluted Total Ops | -8,095.95 | -0.05 | -0.05 | -0.09 | -0.14 |
| EPS Diluted Continuous Ops | -8,055.00 | -0.04 | 0.00 | -0.08 | -0.16 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | -0.01 | 0.02 |
| EBITDA(a) | $-1,473 | $-894 | $-1,133 | $-1,451 | $-2,362 |